What is Oftan Dexa used for?

Oftan Dexa

Active Ingredient:: Dexamethasone Sodium Phosphate
Origin:: EU

Oftan Dexa (Dexamethasone Sodium Phosphate)

Dexamethasone sodium phosphate, the active ingredient in Often Dexa, is a corticosteroid presented as a sterile injectable solution for intramuscular or intravenous use. It is employed to reduce inflammation and modify immune responses in a variety of acute and chronic medical conditions.

GNH India supplies Oftan Dexa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

Manufacturer / TM Owner

Santen Oy

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Oftan Dexa is a corticosteroid that acts on inflammatory and immune pathways across several disease categories.

Allergic reactions: helps reduce severe hypersensitivity symptoms and airway swelling.
Autoimmune disorders: diminishes
Cerebral edema: lowers intracranial pressure associated with tumors or trauma.
Acute inflammation: provides rapid anti‑inflammatory effect in postoperative or traumatic settings.

How It Works

Dexamethasone sodium phosphate is a synthetic glucocorticoid that penetrates cell membranes and binds to cytoplasmic glucocorticoid receptors. The drug‑receptor complex translocates to the nucleus, where it modulates gene transcription, suppressing pro‑inflammatory cytokines and up‑regulating anti‑inflammatory proteins, thereby reducing inflammation and immune activation.

Side Effects

Adverse reactions to dexamethasone sodium phosphate vary with dose, duration and route of administration.

Common Side Effects

Hyperglycemia: elevated blood glucose levels, especially in diabetic patients.
Fluid retention: peripheral edema and weight gain.
Mood changes: irritability, anxiety or insomnia.
Gastrointestinal discomfort: nausea, abdominal pain or dyspepsia.
Local site reactions: pain, erythema or swelling at the injection site.

Serious or Rare Side Effects

Severe infection: increased susceptibility to bacterial, fungal or viral infections.
Adrenal suppression: impaired endogenous cortisol production.
Osteonecrosis: bone tissue death, particularly in weight‑bearing joints.
Psychiatric effects: psychosis, severe depression or mania.
Hypersensitivity: anaphylaxis or severe allergic reactions.

Precautions & Warnings

When using dexamethasone sodium phosphate, clinicians should assess patient history and monitor for systemic effects.

Assess infection risk: evaluate for active or latent infections before initiating therapy.
Monitor glucose: check blood sugar levels in diabetic or pre‑diabetic patients.
Evaluate bone health: consider calcium and vitamin D supplementation for long‑term use.
Review psychiatric history: watch for mood or behavioral changes.
Store at ambient temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Dexamethasone sodium phosphate can modify the pharmacokinetics or pharmacodynamics of several co‑administered medicines.

Major Interactions (Avoid)

CYP3A4 inhibitors: may increase systemic exposure and risk of adverse effects.
Live vaccines: immunosuppression can reduce vaccine efficacy and increase infection risk.
Anticoagulants: enhanced anticoagulant effect leading to bleeding.

Moderate Interactions (Monitor Closely)

Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive risk of gastrointestinal ulceration.
Diuretics: may potentiate electrolyte disturbances, especially hypokalemia.
Antidiabetic agents: may require dose adjustment due to hyperglycaemic effect.

Frequently Asked Questions

Oftan Dexa contains dexamethasone sodium phosphate, a corticosteroid that is used to treat severe allergic reactions, reduce cerebral edema, and manage acute inflammatory states such as postoperative swelling or trauma‑related inflammation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 02 Oct 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.